NPLEx System Releases First Quarter Results for 2015
LUTHERVILLE, Md., May 12, 2015 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion lauded the latest National Precursor Log Exchange (NPLEx) results. NPLEx reported results for Q1 2015, January through March, for the real-time, stop-sale system created by Appriss, Inc.
The breakdown by state in the report shows the total number of boxes reported as purchased, the total number of grams reported as purchased, the total number of boxes and grams that were blocked based on state and federal laws, and the total number of unique individuals reported as purchasing over-the-counter PSE/EPH. The numbers for first quarter this year indicate the laws that are being enforced by NPLEx at the point-of-sale, in real-time, and across state lines. The system also provides data utilized in courts to prosecute those trying to manufacture meth using PSE/EPH.
NADDI Executive Director Charles Cichon states that, "The information shows us that NPLEx continues to be a tremendous tool for pharmacies in stopping the illegal sale of PSE to potential meth-makers."
About NADDI and Public Safety
Established in 1989, the National Association of Drug Diversion Investigators, Inc. (NADDI) is a unique membership organization whose members are responsible for investigating and prosecuting pharmaceutical drug diversion. The organization has proven to be a valuable asset to law enforcement, the pharmaceutical industry and health regulatory personnel. NADDI's objective is simple: to improve the members' ability to investigate, and prosecute, pharmaceutical drug diversion. You can learn about NADDI here: www.NADDI.org
SOURCE The National Association of Drug Diversion Investigators
Share this article